Cotter Douglas A

Avg. Two Year Performance

No purchase track record
(31%) Avg. Sale Return
(14%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return2%2%(8%)(28%)(31%)
Sale Success Rate3 of 53 of 51 of 50 of 50 of 5

Omrix Biopharmaceuticals, I...

Drugs » Biotechnology

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--